About
Gene Therapy Delivery
Areas of Focus
Categories
Drug Delivery & FormulationTaiwan
Team (12)
Avery Wu
GenomeFrontier Therapeutics
team_member
Ben Chung, MM
GenomeFrontier Therapeutics
team_member
Cassian Yee, MD
GenomeFrontier Therapeutics
team_member
Du-Shieng Chien, PhD
GenomeFrontier Therapeutics
team_member
Howard Cheng, MS
GenomeFrontier Therapeutics
team_member
James S. Miser, MD
GenomeFrontier Therapeutics
team_member
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
36
By Phase
PHASE1: 1
By Status
NOT_YET_RECRUITING: 1RECRUITING: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
Today
Hover over trial bars to see details
Recent Trials
NCT06985576Lead Sponsor
Long-term Study to Evaluate Safety and Persistence of GF-CART01
N/ANot yet recruiting
18 participants
Started: May 31, 2026 · Completed: May 31, 2041
NCT06703892Lead Sponsor
A Study to Evaluate the Safety and Clinical Activity of GF- CART01 (CD20/19 CAR T Cell) in Subjects With Relapsed or Refractory B-Cell Hematological Malignancies
PHASE1Recruiting
18 participants
Started: Jun 9, 2025 · Completed: Dec 31, 2027
Locations (1)
Headquarters
New Taipei City, Taiwan
Map
Loading map...